Crossref journal-article
Elsevier BV
Neurobiology of Disease (78)
Bibliography

Cantuti-Castelvetri, I., Keller-McGandy, C., Bouzou, B., Asteris, G., Clark, T. W., Frosch, M. P., & Standaert, D. G. (2007). Effects of gender on nigral gene expression and parkinson disease. Neurobiology of Disease, 26(3), 606–614.

Authors 7
  1. Ippolita Cantuti-Castelvetri (first)
  2. Christine Keller-McGandy (additional)
  3. Bérengère Bouzou (additional)
  4. Georgios Asteris (additional)
  5. Timothy W. Clark (additional)
  6. Matthew P. Frosch (additional)
  7. David G. Standaert (additional)
References 69 Referenced 202
  1. 10.1212/01.WNL.0000046523.05125.87 / Neurology / Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease by Ascherio (2003)
  2. 10.1038/75556 / Nat. Genet. / Gene ontology: tool for the unification of biology. The Gene Ontology Consortium by Ashburner (2000)
  3. 10.1212/WNL.55.9.1358 / Neurology / Parkinson’s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging by Baldereschi (2000)
  4. 10.1159/000080707 / Dev. Neurosci. / A fetal risk factor for Parkinson’s disease by Barlow (2004)
  5. 10.1523/JNEUROSCI.11-05-01325.1991 / J. Neurosci. / Dopamine content and metabolism in mesencephalic and diencephalic cell cultures: sex differences and effects of sex steroids by Beyer (1991)
  6. 10.1093/jnen/63.10.1003 / J. Neuropathol. Exp. Neurol. / DNA chip technology in brain banks: confronting a degrading world by Buesa (2004)
  7. 10.1097/01.jnen.0000190063.90440.69 / J. Neuropathol. Exp. Neurol. / Alpha-synuclein and chaperones in dementia with Lewy bodies by Cantuti-Castelvetri (2005)
  8. 10.1016/j.neurobiolaging.2004.11.008 / Neurobiol. Aging / Somatic mitochondrial DNA mutations in single neurons and glia by Cantuti-Castelvetri (2005)
  9. 10.1016/j.brainres.2004.12.009 / Brain Res. / Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson’s disease by Cass (2005)
  10. 10.1093/bioinformatics/btg410 / Bioinformatics / A benchmark for Affymetrix GeneChip expression measures by Cope (2004)
  11. 10.1097/00001756-200301200-00009 / NeuroReport / Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle by Datla (2003)
  12. 10.1016/j.cub.2006.01.017 / Curr. Biol. / Direct regulation of adult brain function by the male-specific factor SRY by Dewing (2006)
  13. 10.1016/S0006-8993(00)02329-5 / Brain Res. / Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats by Disshon (2000)
  14. 10.1016/0006-8993(95)01566-3 / Brain Res. / Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice by Dluzen (1996)
  15. 10.1016/0892-0362(96)00086-4 / Neurotoxicol. Teratol. / Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice by Dluzen (1996)
  16. 10.1159/000070278 / Neuroendocrinology / Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigrostriatal dopaminergic system by Dluzen (2003)
  17. 10.1002/gepi.1124 / Genet. Epidemiol. / Empirical Bayes methods and false discovery rates for microarrays by Efron (2002)
  18. 10.1073/pnas.95.25.14863 / Proc. Natl Acad Sci. U. S. A. / Cluster analysis and display of genome-wide expression patterns by Eisen (1998)
  19. 10.1016/S0169-328X(99)00265-X / Brain Res. Mol. Brain Res. / Isolation of sex-specific cDNAs from fetal mouse brain using mRNA differential display and representational difference analysis by Eriksson (1999)
  20. 10.1038/3327 / Nat. Med. / Real-time quantitative RT-PCR after laser-assisted cell picking by Fink (1998)
  21. 10.1016/0006-8993(96)00598-7 / Brain Res. / The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent by Freyaldenhoven (1996)
  22. 10.1016/j.brainresrev.2004.07.018 / Brain Res. Brain Res. Rev. / Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease by Fuentealba (2004)
  23. 10.1016/j.pbb.2004.04.022 / Pharmacol. Biochem. Behav. / Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson’s disease by Gillies (2004)
  24. 10.1016/S0896-6273(02)00765-1 / Neuron / Cadherins communicate structural plasticity of presynaptic and postsynaptic terminals by Goda (2002)
  25. 10.1007/s00702-004-0212-1 / J. Neural Transm. / Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes by Grunblatt (2004)
  26. 10.1002/mds.10173 / Mov. Disord. / Genetics of parkinsonism by Gwinn-Hardy (2002)
  27. Haaxma, C.A., et al., in press. Gender differences in Parkinson’s disease. J. Neurol., Neurosurg. Psychiatry (2006 Nov. 10, Epub ahead of print).
  28. 10.1093/hmg/ddg070 / Hum. Mol. Genet. / Genomic convergence: identifying candidate genes for Parkinson’s disease by combining serial analysis of gene expression and genetic linkage by Hauser (2003)
  29. 10.1093/hmg/ddg283 / Hum. Mol. Genet. / Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies by Iwata (2003)
  30. 10.1093/brain/124.6.1125 / Brain / Increased frontal [(18)F]fluorodopa uptake in early Parkinson’s disease: sex differences in the prefrontal cortex by Kaasinen (2001)
  31. 10.1016/S0161-813X(02)00061-X / Neurotoxicology / Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson’s disease by Kelada (2002)
  32. 10.1016/S0006-3223(02)01369-0 / Biol. Psychiatry / Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects by Laakso (2002)
  33. 10.1186/1471-2105-6-129 / BMC Bioinformatics / Considerations when using the significance analysis of microarrays (SAM) algorithm by Larsson (2005)
  34. 10.1007/s002590000279 / Eur. J. Nucl. Med. / Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers by Lavalaye (2000)
  35. 10.1523/JNEUROSCI.20-23-08604.2000 / J. Neurosci. / Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson’s disease and memory by Leranth (2000)
  36. 10.1006/meth.2001.1262 / Methods / Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method by Livak (2001)
  37. {'key': '10.1016/j.nbd.2007.02.009_bib37', 'first-page': '118', 'article-title': 'Gender differences in Parkinson’s disease', 'volume': '21', 'author': 'Lyons', 'year': '1998', 'journal-title': 'Clin. Neuropharmacol.'} / Clin. Neuropharmacol. / Gender differences in Parkinson’s disease by Lyons (1998)
  38. {'key': '10.1016/j.nbd.2007.02.009_bib38', 'first-page': '356', 'article-title': 'Gene expression profiling of sporadic Parkinson’s disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70', 'volume': '1053', 'author': 'Mandel', 'year': '2005', 'journal-title': 'Ann. N. Y. Acad. Sci.'} / Ann. N. Y. Acad. Sci. / Gene expression profiling of sporadic Parkinson’s disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70 by Mandel (2005)
  39. 10.1086/496902 / Am. J. Hum. Genet. / High-resolution whole-genome association study of Parkinson disease by Maraganore (2005)
  40. 10.1007/s100720200082 / Neurol. Sci. / Parkinson’s disease and reproductive life events by Martignoni (2002)
  41. 10.1111/j.1749-6632.1998.tb08230.x / Ann. N.Y. Acad. Sci. / The impact of gender and estrogen on striatal dopaminergic neurotoxicity by Miller (1998)
  42. 10.1016/j.nbd.2005.07.010 / Neurobiol. Dis. / Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson’s disease by Miller (2006)
  43. 10.1111/j.1365-2990.1994.tb00997.x / Neuropathol. Appl. Neurobiol. / Transferrin receptors in the parkinsonian midbrain by Morris (1994)
  44. 10.1176/appi.ajp.158.9.1492 / Am. J. Psychiatry / Striatal dopamine transporters and cognitive functioning in healthy men and women by Mozley (2001)
  45. 10.1002/ana.20064 / Ann. Neurol. / Pael-R is accumulated in Lewy bodies of Parkinson’s disease by Murakami (2004)
  46. 10.1016/S0306-4522(02)00578-X / Neuroscience / Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females by Murray (2003)
  47. 10.1016/S1353-8020(02)00052-4 / Parkinsonism Relat. Disord. / Effect of the neurotoxic dose of methamphetamine on gene expression of parkin and Pael-receptors in rat striatum by Nakahara (2003)
  48. 10.1016/S0168-0102(98)00010-8 / Neurosci. Res. / Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid by Nishino (1998)
  49. 10.1093/hmg/ddg270 / Hum. Mol. Genet. / Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families by Pankratz (2003)
  50. 10.1016/S0169-328X(03)00337-1 / Brain Res. Mol. Brain Res. / Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance by Preece (2003)
  51. 10.1016/S0169-328X(03)00208-0 / Brain Res. Mol. Brain Res. / An optimistic view for quantifying mRNA in post-mortem human brain by Preece (2003)
  52. 10.1038/ng1032 / Nat. Genet. / Microarray data normalization and transformation by Quackenbush (2002)
  53. 10.1016/0169-328X(95)00125-C / Brain Res. Mol. Brain Res. / Effects of sex and estrogen on tyrosine hydroxylase mRNA in cultured embryonic rat mesencephalon by Raab (1995)
  54. 10.1212/WNL.62.11.2010 / Neurology / Risk of Parkinson disease in women: effect of reproductive characteristics by Ragonese (2004)
  55. 10.1016/0166-2236(91)90047-X / Trends Neurosci. / Sexual differentiation of monoaminergic neurons—Genetic or epigenetic? by Reisert (1991)
  56. 10.1016/j.ygeno.2003.09.017 / Genomics / Confirming microarray data—Is it really necessary? by Rockett (2004)
  57. 10.1016/S1353-8020(03)00067-1 / Parkinsonism Relat. Disord. / Depression in Parkinson’s disease: clinical correlates and outcome by Rojo (2003)
  58. 10.1007/s10072-004-0364-7 / Neurol. Sci. / REM sleep behaviour disorder in Parkinson’s disease: a questionnaire-based study by Scaglione (2005)
  59. 10.1001/jama.286.18.2239 / JAMA / Complete genomic screen in Parkinson disease: evidence for multiple genes by Scott (2001)
  60. 10.1002/syn.1084 / Synapse / Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers by Staley (2001)
  61. {'key': '10.1016/j.nbd.2007.02.009_bib61', 'series-title': 'Goodman and Gilaman’s The Pharmacological Basis of Therapeutics', 'first-page': '527', 'article-title': 'Treatment of the central nervous system degenerative disorders', 'author': 'Standaert', 'year': '2005'} / Goodman and Gilaman’s The Pharmacological Basis of Therapeutics / Treatment of the central nervous system degenerative disorders by Standaert (2005)
  62. 10.1016/j.bbr.2004.09.002 / Behav. Brain Res. / Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats by Tamas (2005)
  63. {'key': '10.1016/j.nbd.2007.02.009_bib63', 'first-page': '133', 'article-title': 'Is the cause of Parkinson’s disease environmental or hereditary? Evidence from twin studies', 'volume': '91', 'author': 'Tanner', 'year': '2003', 'journal-title': 'Adv. Neurol.'} / Adv. Neurol. / Is the cause of Parkinson’s disease environmental or hereditary? Evidence from twin studies by Tanner (2003)
  64. 10.1093/bioinformatics/17.6.520 / Bioinformatics / Missing value estimation methods for DNA microarrays by Troyanskaya (2001)
  65. 10.1073/pnas.091062498 / Proc. Natl. Acad Sci. U. S. A. / Significance analysis of microarrays applied to the ionizing radiation response by Tusher (2001)
  66. 10.1016/j.parkreldis.2004.10.007 / Parkinsonism Relat. Disord. / Defining the Parkinson’s disease phenotype: initial symptoms and baseline characteristics in a clinical cohort by Uitti (2005)
  67. 10.1093/aje/kwg068 / Am. J. Epidemiol. / Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity by Van Den Eeden (2003)
  68. 10.1038/sj.npp.1300337 / Neuropsychopharmacology / Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes by Vawter (2004)
  69. 10.1016/S0896-6273(03)00143-0 / Neuron / Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila by Yang (2003)
Dates
Type When
Created 18 years, 6 months ago (March 4, 2007, 6:52 a.m.)
Deposited 1 year, 6 months ago (Feb. 10, 2024, 1:26 p.m.)
Indexed 1 week, 3 days ago (Aug. 27, 2025, 12:22 p.m.)
Issued 18 years, 3 months ago (June 1, 2007)
Published 18 years, 3 months ago (June 1, 2007)
Published Print 18 years, 3 months ago (June 1, 2007)
Funders 0

None

@article{Cantuti_Castelvetri_2007, title={Effects of gender on nigral gene expression and parkinson disease}, volume={26}, ISSN={0969-9961}, url={http://dx.doi.org/10.1016/j.nbd.2007.02.009}, DOI={10.1016/j.nbd.2007.02.009}, number={3}, journal={Neurobiology of Disease}, publisher={Elsevier BV}, author={Cantuti-Castelvetri, Ippolita and Keller-McGandy, Christine and Bouzou, Bérengère and Asteris, Georgios and Clark, Timothy W. and Frosch, Matthew P. and Standaert, David G.}, year={2007}, month=jun, pages={606–614} }